Healthcare shares were fairly flat in pre-market trade on Thursday.
In healthcare stocks news, Receptos ( RCPT ) priced an underwritten public offering of 4.433 million shares of its common stock at a price to the public of $40.25 per share.
Proceeds are expected to be approximately $178.4 million, before deducting offering expenses. Receptos has granted the underwriters a 30-day option to purchase up to an aggregate of 664,950 additional shares of common stock. The offering is expected to close on or about June 24.
And, Actavis plc ( ACT ) said the United States District Court for the District of Delaware has found certain patent claims valid and infringed by Actavis' generic version of Novartis' Exelon Patch.
Actavis said it is reviewing the court's decision and will evaluate all available options, including an appeal.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.